CORZYNA
Identification of Corzyna
| No description |
Google image searchProduct monograph
Active ingredient
ranolazine, 500 MG
DIN: 02510219
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: KYE PHARMACEUTICALS INC.
Date: 03-MAY-2021
ATC:
- C01 — CARDIAC THERAPY (ATC, ATC/DDD, )
- C01E — OTHER CARDIAC PREPARATIONS (ATC, ATC/DDD)
- C01EB — Other cardiac preparations (ATC, ATC/DDD)
- C01EB18 — RANOLAZINE (ATC/DDD)
Reference brand drug: Corzyna
